Transparency Protocol

Crowdsource diverse patient voices to enable a holistic perspective on study protocol design and drugs in market.

A Health
That Pays Off

Giving Patients a
Voice in Clinical

previous arrow
next arrow
Experience the Future of Clinical Trials Now

Transparency Life Sciences’ TPC™ platform brings together the stakeholders who hold key insights into how to optimize your trial design.


Patients and researchers contribute to the design of trials using our online crowdsourcing tool, enabling sponsors to make their protocols more relevant to patient needs and clinical practice.


We use our virtual trial hub that integrates telemedicine, mobile health and cloud technology to conduct virtual trials that are simpler and result in faster, more cost-effective delivery.

Let’s take the next step and work together
Contact Us

Transparency Life Sciences pioneered open sourcing design of clinical trial protocols and was one of the first to execute ‘virtual’ studies; implementation of their model will enable true patient centric clinical research.

Jeffrey Kasher, President, Patients Can’t Wait, LLC; former VP and COO, Global Clinical Development Organization, Eli Lilly and Company

Transparency Life Sciences’ crowdsourcing expertise obtained fresh insights for our protocol assessing metformin in prostate cancer. Their commitment to all-digital clinical trials will benefit patients and investigators, and help achieve more efficient and more informative clinical trials.

Dr. Matthew Galsky, Professor of Hematology-Oncology, Mt. Sinai School of Medicine

We applaud Transparency Life Sciences for being a valued partner of our Foundation, and for creating a model in which patients are more than subjects, but thoughtful collaborators in clinical trial design and execution.

Ginger Spitzer, Executive Director, Foundation for Sarcoidosis Research